全国医保会议16次提“创新”，明年医药产业迎来哪些利好

Core Insights - The National Medical Insurance Administration (NMIA) will utilize its resources and policies to support the innovation and development of China's pharmaceutical industry by 2026 [1][2][3] - The recent national medical insurance work conference emphasized the dual role of medical insurance as both a social welfare tool and an economic driver, aiming to guide the transformation and upgrading of the pharmaceutical industry [1][2] Summary by Categories National Medical Insurance Strategy - The NMIA plans to consolidate the achievements of universal insurance coverage and improve the basic medical insurance system [1] - There will be a focus on supporting the development of commercial health insurance to create a multi-tiered medical security system [1][4] - The NMIA aims to enhance the management of insurance funds to ensure their safety and sustainability [1] Support for Pharmaceutical Innovation - The NMIA will play a strategic purchasing role to foster innovation in the pharmaceutical industry, encouraging healthy competition and differentiated development [2][5] - A total of 949 new drugs have been added to the medical insurance catalog since the establishment of the NMIA, with the latest version including 114 new drugs, marking a record high for innovative drugs [3] - The NMIA has committed approximately 13 trillion yuan in insurance fund expenditures during the 14th Five-Year Plan period, maintaining an annual growth rate of around 10% to provide stable funding for innovation [3] Commercial Health Insurance Development - The NMIA encourages commercial health insurance to complement basic medical insurance and expand coverage for reasonable medical expenses not included in the basic insurance catalog [4][5] - The introduction of a commercial health insurance innovative drug catalog aims to include more high-value, innovative drugs, benefiting a larger patient population [3][5] Technological Innovation and AI Integration - The NMIA is promoting the integration of artificial intelligence in the healthcare sector, encouraging participation from medical institutions, pharmaceutical companies, and research organizations [5][6] - Efforts are being made to create a comprehensive personal health profile for insured individuals, facilitating the application of AI in healthcare services [6] - The NMIA is actively working on a progressive industrial upgrade and payment system for new technologies and products in the healthcare sector [6]